WashU Startups Secure Record $1.7B Investment

St. Louis-based biotech company Wugen, which is developing cell-based immunotherapies for hard-to-treat blood cancers, is among the WashU startups that collectively have attracted a record-setting total of $1.7 billion in private-sector investment over the past year. (Photo: Alise O'Brien Photography)
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.